Filing Details
- Accession Number:
- 0001181431-12-051916
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-09-24 18:14:13
- Reporting Period:
- 2012-09-20
- Filing Date:
- 2012-09-24
- Accepted Time:
- 2012-09-24 18:14:13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1178670 | Alnylam Pharmaceuticals Inc. | ALNY | Pharmaceutical Preparations (2834) | 770602661 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1030617 | Ag Pharma Novartis | Lichtstrasse 35 Basel Switzerland V8 CH 4002 | No | No | Yes | No | |
1114448 | Ag Novartis | Lichtstrasse 35 Basel Switzerland V8 CH 4002 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2012-09-20 | 1,551,896 | $19.42 | 4,051,002 | No | 4 | S | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See footnote |
Footnotes
- These securities are owned directly by Novartis Pharma AG, a direct, wholly-owned subsidiary of Novartis AG. Novartis AG is an indirect beneficial owner of these securities.